4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-047323
Chief Financial Officer sold 33,000 shares at $2.33 ($76,890)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran Chief Financial Officer | 2023-08-24 | Sale 10b5-1 | −33,000 | $2.33 | $76,890 | 258,042 | D |
| Open-market sales · 33,000 sh · avg $2.33 · $76,890 | |||||||
Loading xslF345X05/doc4.xml…